Kindred Bio Goes To The Dogs; Lead Drug Candidate Washes Out By: Benzinga via Benzinga August 21, 2014 at 09:07 AM EDT Kindred Biosciences (NASDAQ: KIN) shares plunged more than 30 percent in Thursday's pre-market action after one of its three lead ... Read More >> Related Stocks: Kindred Biosciences Starwood Hotels & Resorts